Research Article
T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves
Table 7
Impact of acute cerebrovascular accident to T cells populations in biological prosthesis recipients.
| | T cells populations | Healthy donors, | Acute cerebrovascular accident, | No acute cerebrovascular accident, | value |
| | CD3+% | 78.27 (73.07; 82.52) | 65.68 (62.34; 68.66) | 71.84 (65.68; 76.38) | 1-2
1–3 | | CD3+ abs. | 1419.31 (1126.25; 1735.91) | 853.84 (748.08; 1441.86) | 1281.15 (1071.68; 1515.78) | n/s | | CD3+CD8+% | 25.80 (20.64; 33.20) | 19.96 (18.93; 33.45) | 24.52 (18.07; 27.32) | n/s | | CD3+CD8+ abs. | 462.37 (349.70; 647.87) | 259.48 (227.16; 702.45) | 413.12 (310.95; 597.77) | n/s | | CM Tcyt%. | 11.50 (8.70; 16.38) | 3.05 (1.61; 3.93) | 6.30 (4.21; 7.94) | 1-2
1–3
2-3 | | CM Tcyt abs. | 51.69 (36.70; 74.30) | 8.92 (4.17; 21.42) | 26.35 (19.22; 31.72) | 1-2
1–3 | | EM Tcyt% | 31.82 (18.80; 43.55) | 15.97 (14.01; 57.57) | 32.65 (22.67; 38.57) | n/s | | EM Tcyt abs. | 122.56 (74.29; 196.04) | 98.41 (41.43; 130.76) | 120.99 (74.36; 162.12) | n/s | | TEMRA Tcyt% | 26.67 (19.58; 34.93) | 71.45 (26.89; 76.42) | 49.03 (43.46; 56.58) | 1-2
1–3 | | TEMRA Tcyt abs. | 104.32 (72.94; 188.42) | 185.39 (61.08; 536.81) | 198.48 (129.60; 332.12) | 1–3 | | N Tcyt% | 24.46 (16.51; 39.58) | 10.98 (6.52; 11.61) | 13.49 (8.10; 15.83) | 1-2
1–3 | | N Tcyt abs. | 98.47 (56.29; 199.74) | 28.49 (26.37; 45.79) | 43.90 (33.37; 64.74) | 1-2
1–3 | | CD3+CD4+% | 48.06 (41.04; 52.58) | 36.60 (34.28; 40.70) | 43.02 (37.69; 53.87) | 1-2 | | CD3+CD4+ abs. | 835.92 (624.17; 1096.10) | 529.10 (439.20; 719.88) | 723.73 (631.84; 979.38) | 1-2 | | CM Th% | 44.67 (38.42; 49.32) | 46.42 (34.21; 48.77) | 39.46 (35.30; 45.49) | n/s | | CM Th abs. | 338.29 (269.64; 484.11) | 245.60 (214.19; 246.27) | 287.48 (227.73; 445.52) | 1-2
1–3 | | EM Th% | 24.02 (17.54; 30.71) | 26.64 (22.92; 32.53) | 25.82 (17.82; 29.66) | n/s | | EM Th abs. | 197.64 (150.63; 229.90) | 140.95 (100.66; 234.17) | 169.64 (135.15; 237.85) | n/s | | TEMRA Th% | 0.82 (0.37; 1.67) | 1.18 (0.44; 14.03) | 1.64 (0.94; 2.49) | 1–3 | | TEMRA Th abs. | 6.17 (3.11; 13.58) | 6.24 (1.93; 100.99) | 11.71 (6.62; 26.89) | 1–3 | | N Th% | 29.88 (19.81; 36.00) | 25.76 (19.23; 27.88) | 33.39 (24.50; 39.09) | n/s | | N Th abs. | 222.99 (145.88; 369.81) | 136.29 (122.44; 138.43) | 231.64 (159.70; 382.83) | 2-3 | | CD4/CD8 | 2.01 (1.34; 2.44) | 1.93 (1.02; 2.03) | 1.81 (1.39; 2.41) | n/s |
|
|
n/s: not significant.
|
